Biotech Intelligence Platform
The science behind
every biotech bet
PhD-reviewed pipeline analysis, clinical trial scoring, and risk-adjusted valuations. Built for investors who read the data, not just the headlines.
PhD-reviewed
200+ data points
5-dimension BioScore
Aggregating data from
ClinicalTrials.govOpenFDASEC EDGARPubMedUSPTO PatentsInstitutional Holdings
AAPG$19.97ABBV$248.08ABCL$6.79ABSI$10.60ABUS$4.79ABVX$139.90ACAD$26.22ADMA$9.11AGIO$41.23AKTS$27.88ALKS$51.95ALMS$28.32ALNY$298.76AMGN$342.57AMLX$17.77ANAB$66.46ANIP$82.07ANNX$5.79APGE$133.65ARCT$6.97ARDX$5.28ARGX$877.29ARQT$27.74ARVN$8.28ARWR$59.50ASND$270.51ATAI$5.17ATRA$9.72AUPH$15.79AVBP$33.69AVLN$28.05AXSM$233.80AZN$202.83BBIO$85.81BCAX$28.88BCRX$10.45BEAM$24.07BHVN$15.55BIIB$172.34BLTE$149.25BMRN$56.02BMY$58.23BNTX$91.28CAPR$21.50CCCC$4.06CELC$107.58CGEM$18.13CGON$75.24CLDX$39.11CNTA$40.50COAG$38.09COGT$38.87COLL$35.22CORT$91.88CPRX$31.48CRBU$1.93CRNX$83.58CRSP$48.44CRVS$15.67CYTK$84.87DBVT$16.49DFTX$47.07DMRA$28.53DNLI$25.68DNTH$97.54DYN$23.43EDIT$3.26ELVN$51.09ERAS$18.53EWTX$45.41EXEL$56.51EYPT$14.72FDMT$12.30GENB$14.32GERN$1.50GHRS$26.67GILD$140.13GLUE$23.02GMAB$29.00GPCR$53.38GSK$52.78HALO$76.19HCM$11.07HRMY$36.87IBRX$8.23IDYA$36.99IMCR$31.95IMNM$23.35IMTX$9.68IMVT$39.71INCY$93.59INDV$40.50INSM$115.61INVA$22.23IONS$58.25IOVA$4.23IRON$76.59IVA$4.29JANX$16.41JAZZ$243.79JBIO$20.94JNJ$240.97KARD$24.55KLRA$20.68KNSA$63.44KOD$41.28KROS$11.80KRYS$365.80KURA$11.44KYMR$119.36LEGN$27.08LGND$316.24LLY$927.06LNTH$105.64LXRX$2.23MANE$119.60MAZE$30.56MBX$61.05MDGL$536.70MESO$15.46MGTX$13.38MIRM$122.13MLTX$20.36MLYS$28.38MNKD$4.09MPLT$39.28MRK$120.85MRNA$48.77NAMS$35.30NBIX$177.19NBTX$39.95NKTR$70.36NRIX$23.08NTLA$14.21NUVB$5.81NUVL$123.90NVAX$9.33NVO$49.48NVS$152.84OCUL$10.21OLMA$11.91ONC$298.70ORIC$10.85ORKA$86.79PCRX$25.47PCVX$58.20PFE$27.83PGEN$5.33PHAT$12.61PHVS$35.02PRAX$323.81PTCT$84.85PTGX$131.42QURE$42.63RAPP$41.79RARE$33.82RCKT$3.91RCUS$28.92REGN$763.04REPL$10.99RGNX$13.95RIGL$42.55RLAY$20.00ROIV$35.98RVMD$186.89RXRX$3.56RYTM$108.40SANA$3.85SEPN$35.93SION$45.29SLDB$10.40SLS$12.76SMMT$15.25SNDX$23.62SNY$43.50SRPT$22.07SRRK$56.75STOK$31.38SUPNSVRA$6.03SYRE$97.74TAK$16.56TARS$58.13TBPH$16.94TGTX$57.12TLX$11.14TNGX$31.06TRVI$17.84TSHA$6.34TVTX$56.60TYRA$32.75URGN$38.57UTHR$547.06VCEL$47.00VCRE$14.01VERA$42.00VIR$9.96VKTX$38.86VNDA$6.24VOR$19.14VRDN$19.75VRTX$434.30WVE$6.26XENE$68.94XNCR$15.86ZBIO$28.73ZLAB$20.49ZVRA$13.34ZYME$25.88AAPG$19.97ABBV$248.08ABCL$6.79ABSI$10.60ABUS$4.79ABVX$139.90ACAD$26.22ADMA$9.11AGIO$41.23AKTS$27.88ALKS$51.95ALMS$28.32ALNY$298.76AMGN$342.57AMLX$17.77ANAB$66.46ANIP$82.07ANNX$5.79APGE$133.65ARCT$6.97ARDX$5.28ARGX$877.29ARQT$27.74ARVN$8.28ARWR$59.50ASND$270.51ATAI$5.17ATRA$9.72AUPH$15.79AVBP$33.69AVLN$28.05AXSM$233.80AZN$202.83BBIO$85.81BCAX$28.88BCRX$10.45BEAM$24.07BHVN$15.55BIIB$172.34BLTE$149.25BMRN$56.02BMY$58.23BNTX$91.28CAPR$21.50CCCC$4.06CELC$107.58CGEM$18.13CGON$75.24CLDX$39.11CNTA$40.50COAG$38.09COGT$38.87COLL$35.22CORT$91.88CPRX$31.48CRBU$1.93CRNX$83.58CRSP$48.44CRVS$15.67CYTK$84.87DBVT$16.49DFTX$47.07DMRA$28.53DNLI$25.68DNTH$97.54DYN$23.43EDIT$3.26ELVN$51.09ERAS$18.53EWTX$45.41EXEL$56.51EYPT$14.72FDMT$12.30GENB$14.32GERN$1.50GHRS$26.67GILD$140.13GLUE$23.02GMAB$29.00GPCR$53.38GSK$52.78HALO$76.19HCM$11.07HRMY$36.87IBRX$8.23IDYA$36.99IMCR$31.95IMNM$23.35IMTX$9.68IMVT$39.71INCY$93.59INDV$40.50INSM$115.61INVA$22.23IONS$58.25IOVA$4.23IRON$76.59IVA$4.29JANX$16.41JAZZ$243.79JBIO$20.94JNJ$240.97KARD$24.55KLRA$20.68KNSA$63.44KOD$41.28KROS$11.80KRYS$365.80KURA$11.44KYMR$119.36LEGN$27.08LGND$316.24LLY$927.06LNTH$105.64LXRX$2.23MANE$119.60MAZE$30.56MBX$61.05MDGL$536.70MESO$15.46MGTX$13.38MIRM$122.13MLTX$20.36MLYS$28.38MNKD$4.09MPLT$39.28MRK$120.85MRNA$48.77NAMS$35.30NBIX$177.19NBTX$39.95NKTR$70.36NRIX$23.08NTLA$14.21NUVB$5.81NUVL$123.90NVAX$9.33NVO$49.48NVS$152.84OCUL$10.21OLMA$11.91ONC$298.70ORIC$10.85ORKA$86.79PCRX$25.47PCVX$58.20PFE$27.83PGEN$5.33PHAT$12.61PHVS$35.02PRAX$323.81PTCT$84.85PTGX$131.42QURE$42.63RAPP$41.79RARE$33.82RCKT$3.91RCUS$28.92REGN$763.04REPL$10.99RGNX$13.95RIGL$42.55RLAY$20.00ROIV$35.98RVMD$186.89RXRX$3.56RYTM$108.40SANA$3.85SEPN$35.93SION$45.29SLDB$10.40SLS$12.76SMMT$15.25SNDX$23.62SNY$43.50SRPT$22.07SRRK$56.75STOK$31.38SUPNSVRA$6.03SYRE$97.74TAK$16.56TARS$58.13TBPH$16.94TGTX$57.12TLX$11.14TNGX$31.06TRVI$17.84TSHA$6.34TVTX$56.60TYRA$32.75URGN$38.57UTHR$547.06VCEL$47.00VCRE$14.01VERA$42.00VIR$9.96VKTX$38.86VNDA$6.24VOR$19.14VRDN$19.75VRTX$434.30WVE$6.26XENE$68.94XNCR$15.86ZBIO$28.73ZLAB$20.49ZVRA$13.34ZYME$25.88
Live CoverageDeep analysis on the biotech
Deep analysis on the biotech
companies that matter
Click any company to explore pipeline data, financials, ownership, catalysts, and more.
AAPG
Ascentage Pharma Group International
$19.97
ABBV
AbbVie Inc
$248.08
ABCL
AbCellera Biologics Inc
$6.79
ABSI
Absci Corp
$10.60
ABUS
Arbutus Biopharma Corp
$4.79
ABVX
Abivax SA
$139.90
ACAD
ACADIA Pharmaceuticals Inc
$26.22
ADMA
ADMA Biologics Inc
$9.11
AGIO
Agios Pharmaceuticals Inc
$41.23
AKTS
Aktis Oncology Inc
$27.88
ALKS
Alkermes PLC
$51.95
ALMS
Alumis Inc
$28.32
ALNY
Alnylam Pharmaceuticals Inc
$298.76
AMGN
Amgen Inc
$342.57
AMLX
Amylyx Pharmaceuticals Inc
$17.77
ANAB
AnaptysBio Inc
$66.46
ANIP
ANI Pharmaceuticals Inc
$82.07
ANNX
Annexon Inc
$5.79
APGE
Apogee Therapeutics Inc
$133.65
ARCT
Arcturus Therapeutics Holdings Inc
$6.97
ARDX
Ardelyx Inc
$5.28
ARGX
argenx SE
$877.29
ARQT
Arcutis Biotherapeutics Inc
$27.74
ARVN
Arvinas Inc
$8.28
ARWR
Arrowhead Pharmaceuticals Inc
$59.50
ASND
Ascendis Pharma AS
$270.51
ATAI
AtaiBeckley Inc
$5.17
ATRA
Atara Biotherapeutics Inc
$9.72
AUPH
Aurinia Pharmaceuticals Inc
$15.79
AVBP
ArriVent BioPharma Inc
$33.69
AVLN
Avalyn Pharma Inc
$28.05
AXSM
Axsome Therapeutics Inc
$233.80
AZN
AstraZeneca PLC
$202.83
BBIO
BridgeBio Pharma Inc
$85.81
BCAX
Bicara Therapeutics Inc
$28.88
BCRX
BioCryst Pharmaceuticals Inc
$10.45
BEAM
Beam Therapeutics Inc
$24.07
BHVN
Biohaven Ltd
$15.55
BIIB
Biogen Inc
$172.34
BLTE
Belite Bio Inc
$149.25
BMRN
BioMarin Pharmaceutical Inc
$56.02
BMY
Bristol-Myers Squibb Co
$58.23
BNTX
BioNTech SE
$91.28
CAPR
Capricor Therapeutics Inc
$21.50
CCCC
C4 Therapeutics Inc
$4.06
CELC
Celcuity Inc
$107.58
CGEM
Cullinan Therapeutics Inc
$18.13
CGON
CG Oncology Inc
$75.24
CLDX
Celldex Therapeutics Inc
$39.11
CNTA
Centessa Pharmaceuticals PLC
$40.50
COAG
Hemab Therapeutics Holdings Inc
$38.09
COGT
Cogent Biosciences Inc
$38.87
COLL
Collegium Pharmaceutical Inc
$35.22
CORT
Corcept Therapeutics Inc
$91.88
CPRX
Catalyst Pharmaceuticals Inc
$31.48
CRBU
Caribou Biosciences Inc
$1.93
CRNX
Crinetics Pharmaceuticals Inc
$83.58
CRSP
CRISPR Therapeutics AG
$48.44
CRVS
Corvus Pharmaceuticals Inc
$15.67
CYTK
Cytokinetics Inc
$84.87
DBVT
DBV Technologies SA
$16.49
DFTX
Definium Therapeutics Inc
$47.07
DMRA
Damora Therapeutics Inc
$28.53
DNLI
Denali Therapeutics Inc
$25.68
DNTH
Dianthus Therapeutics Inc
$97.54
DYN
Dyne Therapeutics Inc
$23.43
EDIT
Editas Medicine Inc
$3.26
ELVN
Enliven Therapeutics Inc
$51.09
ERAS
Erasca Inc
$18.53
EWTX
Edgewise Therapeutics Inc
$45.41
EXEL
Exelixis Inc
$56.51
EYPT
EyePoint Inc
$14.72
FDMT
4D Molecular Therapeutics Inc
$12.30
GENB
Generate Biomedicines Inc
$14.32
GERN
Geron Corp
$1.50
GHRS
GH Research PLC
$26.67
GILD
Gilead Sciences Inc
$140.13
GLUE
Monte Rosa Therapeutics Inc
$23.02
GMAB
Genmab AS
$29.00
GPCR
Structure Therapeutics Inc
$53.38
GSK
GSK PLC
$52.78
HALO
Halozyme Therapeutics Inc
$76.19
HCM
HUTCHMED (China) Ltd
$11.07
HRMY
Harmony Biosciences Holdings Inc
$36.87
IBRX
ImmunityBio Inc
$8.23
IDYA
IDEAYA Biosciences Inc
$36.99
IMCR
Immunocore Holdings PLC
$31.95
IMNM
Immunome Inc
$23.35
IMTX
Immatics NV
$9.68
IMVT
Immunovant Inc
$39.71
INCY
Incyte Corp
$93.59
INDV
Indivior Pharmaceuticals Inc
$40.50
INSM
Insmed Inc
$115.61
INVA
Innoviva Inc
$22.23
IONS
Ionis Pharmaceuticals Inc
$58.25
IOVA
Iovance Biotherapeutics Inc
$4.23
IRON
Disc Medicine Inc
$76.59
IVA
Inventiva SA
$4.29
JANX
Janux Therapeutics Inc
$16.41
JAZZ
Jazz Pharmaceuticals PLC
$243.79
JBIO
Jade Biosciences Inc
$20.94
JNJ
Johnson & Johnson
$240.97
KARD
Kardigan Inc
$24.55
KLRA
Kailera Therapeutics Inc
$20.68
KNSA
Kiniksa Pharmaceuticals International PLC
$63.44
KOD
Kodiak Sciences Inc
$41.28
KROS
Keros Therapeutics Inc
$11.80
KRYS
Krystal Biotech Inc
$365.80
KURA
Kura Oncology Inc
$11.44
KYMR
Kymera Therapeutics Inc
$119.36
LEGN
Legend Biotech Corp
$27.08
LGND
Ligand Pharmaceuticals Inc
$316.24
LLY
Eli Lilly and Co
$927.06
LNTH
Lantheus Holdings Inc
$105.64
LXRX
Lexicon Pharmaceuticals Inc
$2.23
MANE
Veradermics Inc
$119.60
MAZE
Maze Therapeutics Inc
$30.56
MBX
MBX Biosciences Inc
$61.05
MDGL
Madrigal Pharmaceuticals Inc
$536.70
MESO
Mesoblast Ltd
$15.46
MGTX
MeiraGTx Holdings PLC
$13.38
MIRM
Mirum Pharmaceuticals Inc
$122.13
MLTX
MoonLake Immunotherapeutics
$20.36
MLYS
Mineralys Therapeutics Inc
$28.38
MNKD
MannKind Corp
$4.09
MPLT
MapLight Therapeutics Inc
$39.28
MRK
Merck & Co Inc
$120.85
MRNA
Moderna Inc
$48.77
NAMS
NewAmsterdam Pharma Co NV
$35.30
NBIX
Neurocrine Biosciences Inc
$177.19
NBTX
Nanobiotix SA
$39.95
NKTR
Nektar Therapeutics
$70.36
NRIX
Nurix Therapeutics Inc
$23.08
NTLA
Intellia Therapeutics Inc
$14.21
NUVB
Nuvation Bio Inc
$5.81
NUVL
Nuvalent Inc
$123.90
NVAX
Novavax Inc
$9.33
NVO
Novo Nordisk AS
$49.48
NVS
Novartis AG
$152.84
OCUL
Ocular Therapeutix Inc
$10.21
OLMA
Olema Pharmaceuticals inc
$11.91
ONC
BeOne Medicines Ltd
$298.70
ORIC
ORIC Pharmaceuticals Inc
$10.85
ORKA
Oruka Therapeutics Inc
$86.79
PCRX
Pacira BioSciences Inc
$25.47
PCVX
Vaxcyte Inc
$58.20
PFE
Pfizer Inc
$27.83
PGEN
Precigen Inc
$5.33
PHAT
Phathom Pharmaceuticals Inc
$12.61
PHVS
Pharvaris NV
$35.02
PRAX
Praxis Precision Medicines Inc
$323.81
PTCT
PTC Therapeutics Inc
$84.85
PTGX
Protagonist Therapeutics Inc
$131.42
QURE
uniQure NV
$42.63
RAPP
Rapport Therapeutics Inc
$41.79
RARE
Ultragenyx Pharmaceutical Inc
$33.82
RCKT
Rocket Pharmaceuticals Inc
$3.91
RCUS
Arcus Biosciences Inc
$28.92
REGN
Regeneron Pharmaceuticals Inc
$763.04
REPL
Replimune Group Inc
$10.99
RGNX
Regenxbio Inc
$13.95
RIGL
Rigel Pharmaceuticals Inc
$42.55
RLAY
Relay Therapeutics Inc
$20.00
ROIV
Roivant Sciences Ltd
$35.98
RVMD
Revolution Medicines Inc
$186.89
RXRX
Recursion Pharmaceuticals Inc
$3.56
RYTM
Rhythm Pharmaceuticals Inc
$108.40
SANA
Sana Biotechnology Inc
$3.85
SEPN
Septerna Inc
$35.93
SION
Sionna Therapeutics Inc
$45.29
SLDB
Solid Biosciences Inc
$10.40
SLS
SELLAS Life Sciences Group Inc
$12.76
SMMT
Summit Therapeutics Inc
$15.25
SNDX
Syndax Pharmaceuticals Inc
$23.62
SNY
Sanofi SA
$43.50
SRPT
Sarepta Therapeutics Inc
$22.07
SRRK
Scholar Rock Holding Corp
$56.75
STOK
Stoke Therapeutics Inc
$31.38
SUPN
SUPN
SVRA
Savara Inc
$6.03
SYRE
Spyre Therapeutics Inc
$97.74
TAK
Takeda Pharmaceutical Co Ltd
$16.56
TARS
Tarsus Pharmaceuticals Inc
$58.13
TBPH
Theravance Biopharma Inc
$16.94
TGTX
TG Therapeutics Inc
$57.12
TLX
Telix Pharmaceuticals Ltd
$11.14
TNGX
Tango Therapeutics Inc
$31.06
TRVI
Trevi Therapeutics Inc
$17.84
TSHA
Taysha Gene Therapies Inc
$6.34
TVTX
Travere Therapeutics Inc
$56.60
TYRA
Tyra Biosciences Inc
$32.75
URGN
UroGen Pharma Ltd
$38.57
UTHR
United Therapeutics Corp
$547.06
VCEL
Vericel Corp
$47.00
VCRE
Vicore Pharma Holding AB
$14.01
VERA
Vera Therapeutics Inc
$42.00
VIR
Vir Biotechnology Inc
$9.96
VKTX
Viking Therapeutics Inc
$38.86
VNDA
Vanda Pharmaceuticals Inc
$6.24
VOR
Vor Biopharma Inc
$19.14
VRDN
Viridian Therapeutics Inc
$19.75
VRTX
Vertex Pharmaceuticals Inc
$434.30
WVE
WAVE Life Sciences Ltd
$6.26
XENE
Xenon Pharmaceuticals Inc
$68.94
XNCR
Xencor Inc
$15.86
ZBIO
Zenas BioPharma Inc
$28.73
ZLAB
Zai Lab Ltd
$20.49
ZVRA
Zevra Therapeutics Inc
$13.34
ZYME
Zymeworks Inc
$25.88
Proprietary RatingFive dimensions.
Five dimensions.
One score.
Every company is automatically scored across five weighted dimensions derived from peer-reviewed frameworks in drug development and biotech valuation. AI-powered analysis of clinical trials, FDA data, financials, and more.
7.6/10Buy
Science(20%)
8.4Target validation, MOA novelty, IP/patent strength, preclinical data quality
Clinical(25%)
7.1Trial design rigor (Keegan's 5 Pillars), endpoint quality, statistical significance, safety
Data(20%)
6.8Data completeness, reproducibility, what's NOT reported (red flags), submission readiness
Competitive(15%)
7.6Market position, pipeline diversity, partnership quality, peak sales potential
Regulatory(20%)
8.2FDA pathway/designation, indication success probability, PDUFA timeline, label breadth
Pipeline IntelligenceEvery trial. Every phase.
Every trial. Every phase.
Every risk quantified.
We pull every registered clinical trial from ClinicalTrials.gov, cross-reference with FDA drug applications, and map each compound through our probability-adjusted pipeline model based on indication-specific success rates.
Historical Phase Transition Rates
Phase 1 → 252%
Phase 2 → 328.9%
Phase 3 → NDA57.8%
NDA → Approval90.4%
Overall (P1)7.9%
Source: Keegan, Tables 3.2–3.3 (oncology-adjusted)
Pipeline Tracker4 active programs
mRNA-1283Recruiting
COVID-19 Next Gen
Phase 36,500 pts
mRNA-1345Active
RSV Vaccine
Phase 337,000 pts
INT-1B3Recruiting
Solid Tumors
Phase 2340 pts
mRNA-4157Recruiting
Melanoma (adjuvant)
Phase 31,089 pts
Cash Runway & Burn Analysis
Cash & Investments
$5.8B
Quarterly Burn
$1.2B
Est. Runway
~4.8 quarters
R&D Intensity
148.3%
Revenue vs R&D (5yr)
Revenue
R&D Spend
Financial Deep DiveCash runway is survival.
Cash runway is survival.
We track every dollar.
10-year historical financials, dilution tracking, burn rate projections, and R&D intensity analysis. Biotech-specific metrics that generic screeners miss — because a Phase 3 biotech burning $400M/quarter isn't the same as a SaaS company.
Cash runway with quarterly burn rate projections
Dilution tracker with 5-year share growth alerts
R&D intensity vs. revenue with trend sparklines
Altman Z-Score, Piotroski F-Score, Beneish M-Score
Catalyst CalendarKnow the dates
Know the dates
that move the stock.
PDUFA dates, data readouts, conference presentations, and patent cliffs — mapped to a timeline so you never miss a binary event. Each catalyst is rated by expected magnitude and direction.
Upcoming Catalysts
Mar 2026High
Phase 3 data readout — mRNA-4157 melanoma
Q2 2026High
BLA submission — mRNA-1345 RSV
Jun 2026Med
ASCO presentation — INT-1B3 dose escalation
Q4 2026Critical
PDUFA target date — RSV vaccine
Our MethodologyBuilt on published research,
Built on published research,
not blog posts.
Our analytical framework is grounded in three foundational texts on biotech valuation and drug development.
Keegan
Biotechnology Valuation
Phase transition probabilities, rNPV methodology, indication-specific success rates
Tables 3.2, 3.3, 4.4, 4.11
Mayer Brown
Legal Guide to Biotech
Deal economics, licensing structures, IP portfolio analysis, regulatory pathways
Risk-adjusted NPV frameworks
WIPO
IP Valuation in Pharma
Patent valuation methods, freedom-to-operate analysis, IP lifecycle mapping
DCF, relief-from-royalty, comparable deals
The conviction to invest
starts with the data to
understand the science.
Join investors who evaluate biotech companies with the same rigor the FDA uses to review them.
Get our free daily biotech digest — AI-scored news, catalyst alerts, and pipeline updates.